semaglutide day 1 side effects How Long Do Last? a Doctor's Guide Semaglutide Side Effects: Common vs

VK2735 Research# VK2735's evidence base consists of phase 2 trials: VENTURE (subcutaneous): 176 adults with obesity, 13 weeks, up to 14.7% weight loss from baseline (placebo-adjusted 13.1%) VENTURE-Oral: Oral tablet formulation, 13 weeks, up to 12.2% weight loss vs 1.3% placebo Phase 3 VANQUISH program: Planned but not yet initiated at time of writing Evidence level: Low -- promising phase 2 data only, short duration, small sample sizes, no head-to-head comparisons

Side effects tend to include mild to moderate gastrointestinal issues like vomiting, diarrhea, nausea, and constipation

10.1016/j.psyneuen.2011.04.012 6 AsadiS.GholamiM

Available at our Lincoln Park clinic or via telehealth across Illinois

de Ligny et al

Kahn, Metabolites as regulators of insulin sensitivity and metabolism